Metraipolis › archive › dc_5abe05bf81ae

Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient… — Europe PMC PMID:42357306

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42357306
DOI: 10.3390/pharmaceutics18060690
License (as archived): solo-consultazione
Archived: 2026-11-01T02:58:53.797Z
SHA-256 of the archived text: 1b344a06d06a5a087a83617d214dd119fac3f2d8ad23d3608b07ea76da7cdd69
Stable URL of this page: https://metraipolis.com/documento/dc_5abe05bf81ae

How to cite

Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient… — Europe PMC PMID:42357306 — Europe PMC (en), https://europepmc.org/article/MED/42357306 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5abe05bf81ae (Metraipolis archive dc_5abe05bf81ae, sha256 1b344a06d06a5a087a83617d214dd119fac3f2d8ad23d3608b07ea76da7cdd69)

BibTeX

@misc{dc5abe05bf81ae,
  title = {Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient… — Europe PMC PMID:42357306},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42357306},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5abe05bf81ae; sha256 1b344a06d06a5a087a83617d214dd119fac3f2d8ad23d3608b07ea76da7cdd69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357306. Agents can read the archived copy with the MCP tool read_document.